TechGuru another reply to your post. Thanks again for your excellent explanation on continuing the trial and the positive changes. I do have a question for you. Why the hell didn't the DSMC or the fda put all these restrictions on Rem and the other three as they're doing to Cytodyn? Why are they putting all these stringent processes on Leronlimab and not on any of the other molecules that are being pushed in front of leronlimab? Yes, I know why because we are not big pharma and not gilead, Regeneron, etc. etc. We have to prove ourselves way, way beyond proven or really still unproven molecules to the extent of ad nauseam

Thanks again for all your contributions and your posts over the years here, GTU

HCIT